ORLOFF JOHN J (EVP, Research & Development) reported 1 transaction at ALEXION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/23/2021ACC: 0000899866-21-000062
Officer· EVP, Research & Development
Since Feb 2019
-146.51K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
146.51K disposed
Non-Derivative Transactions1
Common Stock, par value $.0001 per share
Direct
Shares
−146.51K
Price / share
—
Trade value
—
% of position
New position
7/21/2021
146.51K→0.00
Total
Net shares
−146.51K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 7/21/2021 | D · Disposition | −146.51K | — | — | New position | 146.51K | 0.00 |
| Total | −146.51K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported